Gesynta Pharma AB

Active
559103-6628Limited company (AB)Registered 2017STOCKHOLM

Key figures

342 933 kr
Revenue 2025
+170,1%
Average annual growth 2023–2025
0100 k200 k300 k400 k202320242025

Key figures

2025

Summary: Gesynta Pharma AB

What kind of company is it?

Gesynta Pharma AB (org. no. 559103-6628) is a limited company (AB). The company was registered in 2017 and has existed for 9 years. Registered seat: Stockholm. Industry according to Statistics Sweden: other research and experimental development on natural sciences and engineering (SNI 72109).

How is the company doing financially?

Net sales in financial year 2025 were 342 933 kr. From 2023 to 2025, net sales grew by an average of 170 % per year. Financial year 2025 ended with a loss of 88 209 803 kr. The company made a loss in all 3 reported financial years. Employees in financial year 2025: 4 (previous year: 3). Net sales per employee were 85 733 kr. At the end of financial year 2025, total assets were 212 804 063 kr and equity 191 725 279 kr (equity ratio 90,1 %).

Where does the data come from and how up to date is it?

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 10 people. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Summary of annual reports2023–2025
202320242025
Sales revenue47 0000342 933
Profit for the reporting year−19 926 821−15 224 569−88 209 803
Retained earnings of previous periods———
Total assets15 066 00028 170 000212 804 063
Total liabilities2 875 75322 329 72221 078 784
Total equity12 190 2475 840 278191 725 279
Employees334

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.